Air Ambulance Services Market Global Analysis, Opportunities and Forecast To 2025

The global air ambulance services market is expected to reach USD 8.2 billion by 2025, according to a new report by Grand View Research, Inc. Increasing incidents of life-threatening diseases, such as cardiovascular disorders, that require emergency medical response support the lucrative growth of the market over the forecast period. In addition, increasing awareness about air medical transport services also spurs growth of this market. Furthermore, Availability of reimbursement in developed countries, such as the U.S., helps people avail these services despite the high cost.

                                     View summary of this report, Click Here

Improving global economy led to increased spending, which resulted in increased spending on healthcare. The per capita healthcare expenditure has increased exponentially over the last couple of decades. This per capita health expenditure increased by about 55.0% from 1996 to 2014 as published by The World Bank Group. As a result, the demand for these services has been increasing over the forecast period.

This industry is capital intensive, yet there exhibits constant entry of new players, which has helped maintain the supply-demand balance in fierce market place. For instance, in 2012 there were more than 300 players operating in this space with around 1,300 aircrafts, and this number is likely to increase over the forecast period.

Further key findings from the study suggest:

• Rotary-wing air ambulance services, which include helicopter-based services, held a lucrative share in 2015. Easy usability of helicopters and low cost of these services governed their dominance.
• Fixed-wing services include specialized aircrafts having medical facilities and dedicated crew. Rising medical tourism and operability of these aircrafts in adverse weather conditions are few reasons for their increased demand.
• Hospital based service dominated service model segment in 2015 and also anticipated to grow at healthy rate over the forecasts period.
• North America dominated the global air ambulance market in 2016 due to established infrastructure for air medical transport.
• Asia Pacific is anticipated to gain lucrative share over the forecast period. Strengthening economy, especially of countries such as India and China, investments from global conglomerates, and improving business opportunities are likely to provide growth avenues for players.
• Some of the key players in this vertical include AMR; PHI Air Medical; Scandinavian Air Ambulance; IAS Medical; Express AirMed Transport; Native American Air Ambulance; Lifeguard Air Ambulance, REVA Air Ambulance and Acadian.
• Strategic initiatives undertaken by these players include collaboration, service portfolio expansion, and partnerships with business firms & sports and entertainment events.

For Sample Request Send Us Here : https://goo.gl/yecS1f

Rising prevalence of chronic diseases such as cardiac and neurological disorders is expected to be the major factor driving the electroceuticals/bioelectric medicine market growth

The global electroceuticals/bioelectric medicine market is expected to reach USD 35.5 billion by 2025, according to a new report by Grand View Research, Inc. Rising geriatric population is the major factor that is expected to propel growth during the forecast period. Aging population is prone to various diseases such as cardiac arrhythmias, Parkinson's disease, Alzheimer's disease, epilepsy, and depression. There are various advanced electroceuticals including implantable cardioverter defibrillators, cochlear implants, cardiac pacemakers, and spinal cord stimulators, which can be used for the treatment of these conditions. 

Increasing investment in the development of advanced bioelectric medicine is another major factor supporting the growth of the electroceuticals market. For instance, in FY 2016, Medtronic, a leading bioelectric medicine manufacturer, invested around USD 2,224 million in R&D for development of advanced products. Technological advancements in these products propel their adoption in treatment of chronic diseases such as cardiac arrhythmias and Parkinson's disease. The technological advanced electroceuticals provide high reliability and efficiency during treatment.

View summary of this report, Click Here 

Further Key Findings From The Report Suggest:

• Implantable cardioverter defibrillators segment was the largest revenue-generating segment of the electroceuticals market in 2016 owing to large application of these products for the treatment of arrhythmia
• The implantable electroceuticals devices segment accounted for the largest revenue share in the bioelectric medicine market in 2016 owing to technological advancements
• In the application segment, the arrhythmia segment accounted for the largest share in 2016 and is expected to maintain its dominance throughout forecast period
• The hospitals dominated the electroceuticals market in terms of revenue in 2016 due to the escalating number of electroceutical devices implant procedures in hospitals
• The North America bioelectric medicine market is the leading regional sector and accounted for the largest revenue share in 2016 mainly due to the existence of large number of medical devices companies in this region
• The Asia Pacific region is expected to grow at a highest growth rate during the study period. The developing healthcare infrastructure and rising healthcare awareness in the Asian countries such as China and India is a major factor contributing to the growth in this region
• Some of the major players include Medtronic; St. Jude Medical; Boston Scientific Corporation; Cochlear Ltd.; Sonova; LivaNova PLC; Biotronik; Nevro Corp.; SECOND SIGHT; and electroCore LLC. 

Click Here For Access Full Report : https://goo.gl/yLgNPc

Click Here For Request Sample Report :https://goo.gl/vSuZpy

Surging demand for anti-wrinkle creams, anti-aging solutions, and expanding cosmetic industry contribute to the growth hyaluronic acid row material market

The global hyaluronic acid raw material market is expected to reach a value of USD 7.25 billion by 2024, according to a new report by Grand View Research, Inc. The increasing use of hyaluronic acid in various medical applications, such as osteoarthritis, wound healing, postoperative adhesion, tympanic membrane repair, tumor diagnosis, fracture healing, and soft tissue repair is expected to fuel the market growth over the forecast period.

View summary of this report, Click Here 

The orthopedics segment dominated the overall market in 2015 with the highest revenue generation. The increasing geriatric population base, rising incidence of osteoarthritis, and growing adoption of viscosupplements in the treatments contribute to the large market share of this segment. Furthermore, the drug delivery segment is projected to be the fastest growing over the forecast period with a significantly higher CAGR. The increasing R&D activities focusing on targeted drug delivery systems and growing usage of hyaluronic acid in anti-cancer drug delivery is expected to contribute to the market growth.

The increasing women population of age 35 to 65 years across the globe engenders a greater demand for anti-aging cosmetic and aesthetic treatments. Owing to the distinctive viscoelastic and moisturizing properties coupled with lower toxicity levels offered by hyaluronic acid-based products, the demand for this polymer in dermal fillers as well as in the treatment of vesicoureteral reflux is expected to experience growth. Thus, it is anticipated that the need for such products will serve as a high impact driver for the hyaluronic acid products over the forecast period. Based on the statistics of the International Society of Aesthetic Plastic Surgery in 2014, there were approximately 20 million cosmetic procedures performed globally, of which nearly 13.5% of the procedures were HA-based non-surgical procedures.

Some of the top countries recording a majority of the aesthetic treatments in 2014 were the U.S., Brazil, Japan, South Korea, Mexico, Germany, France, and Colombia. Medical tourism for cosmetic surgery in the U.S. plays a very important role in aiding the uptake of HA-based products and procedures, which is expected to drive the market in the coming few years.

Further Key Findings From the Study Suggest:

• In 2015, orthopedics was the largest application segment, owing to rising prevalence and incidence of osteoarthritis
• The introduction of FDA-approved hyaluronic acid-based viscosupplements such as ORTHOVISC and MONOVISC is expected to boost usage over the next 8 years
• Some of the key market players are Salix Pharmaceuticals; ALLERGAN; Lifecore Biomedical, LLC; Shiseido Co., Ltd.; Anika Therapeutics, Inc.; Smith & Nephew; Maruha Nichiro Corporation; Ferring B.V.; SEIKAGAKU CORPORATION; Genzyme Corporation; F. Hoffmann-La Roche Ltd., Contipro a.s.; Zimmer Biomet; and others

Click Here For Access Full Report : https://goo.gl/vnkPEC

Rising incidences of sports related injuries worldwide is anticipated to be high impact rendering driver for the lucrative growth of sports medicine market

The global sports medicine market is expected to reach USD 12.5 billion by 2025, according to a new report by Grand View Research, Inc. Rising incidences of sports related injuries worldwide is anticipated to be high impact rendering driver for the lucrative growth of sports medicine market.

As per data published by the U.S. Consumer Product Safety Commission’s National Electronic Injury Surveillance System (NEISS) in 2012, around 1.9 million people encountered such injuries. Additionally, with aid of fitness awareness initiatives from government and health organizations, people nowadays are more focused on physical exercise including gym, outdoor sports and others fitness activities. With this people are more prone to injuries, hence contributing to the remunerative growth of market.

Additionally, influx of technologically advanced products such as minimally invasive surgical products is anticipated to increase the demand for these devices over the forecast period. For instance, in March 2015, Smith & Nephew launched Q-FIX implant which assists surgeon’s flexibility for all sutures anchors along with fixation and pull-out strength equivalent to large sized anchors.

Similarly, in May 2014 Smith & Nephew acquired ArthroCare, a medical device company based in the U.S. specialized in tissue repair devices. This acquisition helped the company to enrich its sports medicine product portfolio.

View summary of this report, Click Here 

Further key findings from the study suggest:

• Body reconstruction and repair devices consisting of surgical equipment, soft tissue repair, and bone reconstruction devices held significant share in 2016 and also this segment is anticipated to exhibit lucrative growth rate over the forecast period.
• Knee-related applications held largest market share in 2016.The knee injuries are the most frequent in most of the games such as soccer, basketball, bicycle, and running which supported the dominion in application segment.
• In the therapeutic segment, cardiology, IVD, and drug delivery are the top performing segments. Rising incidences of cardiac failures, infectious diseases and high research activity in the field of drug delivery are certain vital impact rendering factors.
• North America, held commanding shares in global sports medicine market. Improved healthcare infrastructure and high healthcare expenditure are key factors responsible for growth. In addition, presence of organizations which are dedicated in field of sports medicine such as the American College of Sports Medicine (ACSM) facilitated availability of adequate and qualified staff.
• The key players of the industry include Stryker Corporation, Arthrex, ArthroCare, Tornier N.V., Wright Medical Technology, DJO Global, Otto Bock Healthcare, Ossur HF, Zimmer Holdings Inc., and Smith & Nephew Plc.

Click Here Access Full Report : https://goo.gl/kCS43w

Retinal Surgery Devices Market Growth Is Expected To Reach USD 3.06 Billion By 2025

The unprecedented growth is presumed to be a consequence of growing prevalence of retinal eye disorders such as retinal detachment, macular degeneration, amblyopia, and others. Rising patient preference for minimally invasive surgeries is believed to be one of the major growth contributory factors. The increasing demand is predicted to be a result of associated benefits such as improved cost-efficiency, safety, rapid recovery, efficacy, and reduced hospital stay. Other advantages include less incision wounds and reduced postsurgical complications that lead to higher patient satisfaction.

The market is also driven by technological upgradations that are responsible for heightened inclination of physicians, thereby, widening the scope for greater adoption of retinal surgery devices in future. The technologically advanced devices are equipped with fundus imaging units, micro incision technology, endoillumination systems. These advancements are primarily witnessed in surgical instrumentation to facilitate easy & safe operative procedure. For instance, launch of VersaVIT 2.0 vitrectomy machine which is equipped with LED illumination system, 3 vitrectomy packs and adjustable chandelier fiber. Similarly, 23-Gauge fragmentation needle that eliminates the need to enlarge sclerotomy and achieve enhanced visualization, intraoperative efficiency and control.

View summary of this report, Click Here 

Further key findings from the report suggest:

• Retinal laser equipment are predicted to observe exponential growth owing to consistency in usage of wide range of retinal operative procedures, high cost-efficiency, availability, and easy operability of the products
• Diabetic retinopathy emerged as the largest application segment in 2016 as a consequence of high prevalence, raising the clinical urgency to adopt retinal surgery devices, thereby, fueling their penetration scope over the coming years
• Hospitals held the largest share in end-use segment due to high patient volume, consistent readmissions, and easy availability of high-end equipment
• North America accounted for the largest share, which can be attributed to the extensive R&D activities that are likely to provide platform for growth through consistent new product approvals
• The market in Asia Pacific is projected to witness substantial growth over the next decade, due to growing awareness pertaining to availability and benefits of these devices, further triggering significant penetration
• Some of the key players of the market include Baush & Lomb Incorporated, IRIDEX Corporation Synergetics, Inc., accounting for the dominant share of retinal surgery devices market in 2016
• The competition is marked by companies indulging in number of mergers & acquisitions, distribution agreements, and product approvals leading to significant growth
• For instance, in February 2017, IRIDEX Corporation received FDA approval for its CYCLO G6 which has combined trans-illumination and laser fiber thereby expanding their product portfolio

Click Here For Access Full Report : https://goo.gl/JRZQJ1

Respiratory Diseases Testing Market Worth Is Expected To Reach USD 6.7 Billion By 2025

The market is driven by the rising prevalence of respiratory diseases. As per Forum of International Respiratory Societies, more than 200 million people across the globe suffered from Chronic Obstructive Pulmonary Disease (COPD) and 235 million suffered from asthma in 2014. In addition, the source stated that more than 50 million people struggle with occupational lung diseases annually. Thus, constantly growing target patient population is anticipated to drive the growth.

The adoption of innovative technologies, such as Computed Tomography (CT), for COPD diagnosis is expected to drive the growth. The other new technology in acute medical management of COPD is pulse oximeter that is used for outpatient monitoring.  Airway management plays a main role in testing and management of COPD. Also, with recent technological innovations, there has been a 12.1 % increase in the use of Noninvasive Mechanical Ventilation (NIV) for management of COPD. Along with technological advancements, use of digital radiography (X-ray) and advanced portable spirometers is gaining momentum in the market.

View summary of this report, Click Here 

Further key findings from the study suggest:

• The growing prevalence of COPD and asthma across the globe is expected to increase the demand for respiratory disease testing devices and thereby drive the market growth
• In products, imaging tests held the largest share in 2016 due to rapid development and adoption of innovative technologies
• In respiratory measurement, spirometers, pulse oximeters, ventilators, capnographs, and other noninvasive ventilators used for measurement of lung capacity are expected to grow at a rate of more than 4% over the forecast period
• In end-use, hospitals segment held the largest share in 2016 and is anticipated to grow over the forecast period
• North America the largest market share in 2016. Growing prevalence of respiratory diseases such as COPD, asthma is increasing the demand for respiratory disease testing/diagnostic in North American countries.
• Asia Pacific region is expected to grow at the fastest rate during the forecast period. This growth can be attributed to various factors such as improving health care infrastructure and increasing patient awareness regarding the availability of new diagnostic techniques for respiratory diseases, such as COPD & asthma.
• Some of the major players competing in this market include, but are not limited to, Becton Dickinson (Carefusion Corporation); Koninklijke Philips N.V. (Respironics); ResMed Company; Fischer & Paykel; and Medtronic. These players are strong brands in the market as they have elaborate product portfolios in respiratory disease testing market.

Click Here For Access Full Report : https://goo.gl/3wqMw5

Endoscopic Vessel Harvesting Systems Market Growth Is Expected To Reach USD 3.4 Billion By 2025

Growing inclination of the patient population toward minimally invasive cardiac surgeries is one of the key factors expected to drive the market in the coming few years.

The introduction of endoscopic vessel harvesting technology in the field of cardiac surgery was a significant milestone in 1996. According to estimates by the Texas Heart Institute, every year over 200,000 procedures were performed in the U.S. Also, based on the statistics published by the department of surgery (Washington University School of Medicine in St. Louis), they perform Coronary Artery Bypass Grafting (CABG) surgeries on approximately 0.5 million people very year. The growing demand for these procedures and technologically advanced surgical procedures are among few factors anticipated to boost the market over the forecast period.

The presence of favorable reimbursement policies in the U.S. pertaining to CABG surgeries is anticipated to increase the number these surgeries. On July 2016, the Department of Health & Human Services announced that it will begin implementing bundled payment models for high-quality, coordinated cardiac and hip fracture care. The market is highly concentrated with a limited number of products and market players operating in this space. Many studies stated that the open vessels harvesting technique is as effective as minimally invasive vessels harvesting technique. However, the growing awareness regarding benefits of Endoscopic Vessels Harvesting (EVH), such as minimally invasive nature, less complications, and quick recuperation are some of the factors that are anticipated to propel its growth during the forecast period.

View summary of this report, Click Here 

Further Key Findings From the Report Suggest:

• The global endoscopic vessel harvesting system market size was estimated at USD 1,881.7 million in 2016 and is expected to grow at a CAGR of 6.1% from 2017 to 2025
• Reusable EVH systems emerged as the largest product segment in 2015 and is estimated to generate revenue over USD 2,136.0 million by 2025
• Global disposable EVH systems was USD 639.3 million in 2016 and is anticipated to witness fastest growth over the next 8 years
• The industry in Asia Pacific is projected to witness substantial growth over the next decade owing to various developments across major economies in the region. The regional market is expected to grow at a CAGR of 7.7% from 2017 to 2025
• Some of the key players including MAQUET Holding B.V. & Co. KG; CARDIO MEDICAL GmbH; Terumo Cardiovascular Group; Med Europe S.r.l. (Elite Life Care); LivaNova plc. (Sorin and Cyberonics); and Saphena Medical, Inc. dominated the global endoscopic vessels harvesting systems market. 

Click Here For Full Report :      https://goo.gl/vSuZpy

Craniomaxillofacial (CMF) Devices Market Growth Is Expected To Reach USD 2.68 Billion By 2025

Increasing incidences of facial fractures and demand for minimally invasive surgery for reconstruction are expected to drive the CMF devices market over the forecast period. The associated benefits with minimally invasive reconstructive surgeries such as faster recovery, minimal incision to the body, and less complications associated with the surgery are anticipated to contribute further toward the market growth. 

The introduction of technologically advanced procedures such as robotic arm assisted CMF surgery and bioabsorbable implants for cranial fixation are expected to drive the demand for CMF systems. The advancement such as amplified use of virtual plating technology and development of cost effective thoracic fixation devices are attributing toward the rising demand.

The market is competitive in nature as the manufacturers are involved in new product development strategies to increase their market penetration. Also, the companies are entering into collaborations and research alliance with other market players to increase their product portfolio. Various software and virtual three-dimensional (3D) technologies are adopted by companies to gain competitive advantage. For instance, the introduction of technologically advanced 3D printing allows manufacturers to integrate materials from both facial and cranial reconstruction is expected to gain popularity in coming years.

View summary of this report, Click Here 

Further Key Findings From the Study Suggest:

• CMF plate and screw fixation dominated the product segment of CMF devices as of 2016, owing to increasing number of CMF trauma and reconstruction procedures which are non-elective
• Temporomandibular joint (TMJ) replacement product segment is expected to show lucrative growth over the forecast period
• Metallic implants held the largest revenue share owing to the advantage associated with it, such as less corrosive nature and provide rigid support to the fixators
• CMF devices find the largest application in neurosurgery owing to increasing CMF procedures in the oncology and neurovascular surgery treatments
• Asia Pacific region is anticipated to register rapid growth in coming years owing to the presence of high unmet needs coupled with increasing patient awareness levels and improving healthcare infrastructure
• Three-dimensional printing allow integration of new material for reconstruction and cranial surgery, this attracts more manufacturers for the investments in R&D for the development of advanced products
• Key players operating in this market include Johnson & Johnson (DePuy Synthes), Medtronic Inc., and Zimmer-Biomet Inc. which make the entry for small organizations difficult
• Moreover, stringent norms for product approval and post-approval performance monitoring which are regulated by authorities such as the U.S. FDA and American Academy of implant may act as a threat for new participants

Click Here For Access Full Report:  https://goo.gl/H5ZP5K